
Medical News Today
- A new study investigated why different obesity treatments, including diets, surgeries and new medications like GLP-1 receptor agonists, such as semaglutide and tirzepatide, lead to varying times at which weight loss plateaus.
- Utilizing a mathematical model, the research examines how these interventions alter the body’s regulation of energy intake and expenditure, affecting the duration of effective weight loss.
Follow the link below to Medical News Today to read the full story:
Information Source: https://www.medicalnewstoday.com